John H. Kempen
About
In The Last Decade
John H. Kempen
182 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Ophthalmology 6.1k
- Epidemiology 1.8k
- Radiology, Nuclear Medicine and Imaging 1.4k
- Rheumatology 1.0k
- Pulmonary and Respiratory Medicine 636
Countries citing papers authored by John H. Kempen
This map shows the geographic impact of John H. Kempen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Kempen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Kempen more than expected).
Fields of papers citing papers by John H. Kempen
This network shows the impact of papers produced by John H. Kempen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Kempen. The network helps show where John H. Kempen may publish in the future.
Co-authorship network of co-authors of John H. Kempen
This figure shows the co-authorship network connecting the top 25 collaborators of John H. Kempen. A scholar is included among the top collaborators of John H. Kempen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Kempen. John H. Kempen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | Cataract-related blindness and vision impairment in 2020 and trends over time in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. | 12 |
| 7 | 33 | |
| 8 | Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases. | 1 |
| 9 | 20 | |
| 10 | Global Prevalence of Blindness and Distance and Near Vision Impairment: Magnitude, Temporal Trends, and Projections | 3 |
| 11 | Estimated Prevalence of Visual Impairment in Sub-Saharan Africa (2015) | 0 |
| 12 | 65 | |
| 13 | 4 | |
| 14 | Risk of Elevated Intraocular Pressure (IOP) in Pediatric Non-infectious Uveitis | 0 |
| 15 | Incidence and Risk Factors for Ocular Hypertension in Adults with Non-infectious Uveitis | 1 |
| 16 | Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial | 1 |
| 17 | 156 | |
| 18 | 124 | |
| 19 | The Prevalence of Diabetic Retinopathy in the United States | 5 |
| 20 | The Prevalence of Age-Related Macular Degeneration in the United States, a Meta-Analysis | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.